Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery-focused on Beta Cell Function and Insulin Sensitivity Changes

NCT03038373 is registered in ClinicalTrials.gov with Dasman Diabetes Institute as lead sponsor.

NCT NCT03038373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03038373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery-focused on Beta Cell Function and Insulin Sensitivity Changes
Lead sponsor
Dasman Diabetes Institute
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2012
Completion date
December 31, 2024
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

morbid obesity, type2 diabetes